Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Location of a VIPoma by Iodine-123-Vasoactive Intestinal Peptide Scintigraphy

Irene Virgolini, Amir Kurtaran, Maria Leimer, Klaus Kaserer, Markus Peck-Radosavljevic, Peter Angelberger, Peter Hübsch, Milos Dvorak, Peter Valent and Bruno Niederle
Journal of Nuclear Medicine September 1998, 39 (9) 1575-1579;
Irene Virgolini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Kurtaran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Leimer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Kaserer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Peck-Radosavljevic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Angelberger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Hübsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milos Dvorak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Valent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Niederle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 9
September 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Location of a VIPoma by Iodine-123-Vasoactive Intestinal Peptide Scintigraphy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Location of a VIPoma by Iodine-123-Vasoactive Intestinal Peptide Scintigraphy
Irene Virgolini, Amir Kurtaran, Maria Leimer, Klaus Kaserer, Markus Peck-Radosavljevic, Peter Angelberger, Peter Hübsch, Milos Dvorak, Peter Valent, Bruno Niederle
Journal of Nuclear Medicine Sep 1998, 39 (9) 1575-1579;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Location of a VIPoma by Iodine-123-Vasoactive Intestinal Peptide Scintigraphy
Irene Virgolini, Amir Kurtaran, Maria Leimer, Klaus Kaserer, Markus Peck-Radosavljevic, Peter Angelberger, Peter Hübsch, Milos Dvorak, Peter Valent, Bruno Niederle
Journal of Nuclear Medicine Sep 1998, 39 (9) 1575-1579;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • GEP-NETS update: Functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs)
  • Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
  • Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
  • Google Scholar

More in this TOC Section

  • Response to Treatment with Yttrium 90-DOTA-Lanreotide of a Patient with Metastatic Gastrinoma
  • Flare Response Seen in Therapy for Osteomalacia
  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire